10th Risk Evaluation & Mitigation Strategies Summit – 10th Risk Evaluation & Mitigation Strategies Summit

ExL Events is proud to announce the 10th Anniversary of the REMS Summit! As the select event for risk evaluation and mitigation strategy professionals, this summit convenes REMS stakeholders to inform the design and redesign of REMS programs. Attendees acquire the tools and strategies to better integrate with healthcare systems by engaging with healthcare providers, pharmacists and patient advocates—key REMS stakeholders—who illuminated the particular burdens that REMS imposes.

The diverse insights of varying stakeholders are complemented by the comprehensive elucidation of information and strategies. This summit delivers sessions on research-based risk management strategies and poignant lessons from Implementation Science. Attendees are provided with proven methods and vetted technologies to adopt and/or adapt to bolster the efficacy of their REMS programs. The 10th REMS Summit is continues to be the preeminent event for updates related to new regulations and emerging issues related to REMS including standardization, evaluation, and structured product labeling.

Learn from and interact with your peers, as well as crucial stakeholders and distinguished thought leaders who comprise this year’s speaking faculty.

We welcome you to witness firsthand why our event remains the conference of choice for REMS professionals.

Top Five Reasons to Attend

  1. Comply with regulations pertaining to standardization and evaluations
  2. Assess REMS efficacy with proven and progressive methods
  3. Get the up-to-date on structured product labeling and what you should be doing to prepare
  4. Ensure safe medication use by vetting consumer and health technologies based on their impact on patient outcomes and safety
  5. Lesson the burden on stakeholders with a comprehensive understanding of their nuanced needs and stressors

Who Should Attend

This event is ideal for professionals from payers and pharmaceutical, biotechnology and medical device companies with responsibilities in the following areas:

  • REMS
  • Risk Management
  • Pharmacovigilance/Surveillance
  • Medical Director
  • Quality Assurance
  • Drug/Product Safety
  • Clinical Risk Management
  • Lifecycle Management
  • Regulatory Affairs/ legal/ compliance
  • Clinical Affairs
  • Clinical Data Management
  • Clinical Operations
  • Clinical Risk Management Compliance
  • Epidemiology/Pharmacoepidemiology
  • Marketing

This conference is also of interest to:

  • Risk Safety and REMS Service Providers
  • Data Management Service Providers
  • Consultancies
  • Dashboard and Metrics service Providers
  • Law Firms
  • Healthcare Information Marketing and Technology Providers